Human Umbilical Cord–Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical StudyFatima Jamali, Abdalla Awidi, Said Dahbour et al.|Cell Transplantation|2024Cited by 25
Natural conditioning of mesenchymal stem cells from multiple sclerosis patients enhances their immune-modulating potentialFatima Jamali, Abdalla Awidi, M. Hassouneh et al.|Cytotherapy|2019Cited by 0